Our research program builds on more than a century of innovation and spans a diverse range of investigative areas, including researching new treatments for heart disease. We’re pioneering new devices, medications, imaging tests, therapies, and technologies to revolutionize care for everyone affected by heart disease.
Our physicians and patients are engaged in more than 100 national and international clinical trials. That means AHN patients have access to some of the newest, most promising treatment options for heart disease.
Physicians and researchers at the Cardiovascular Research Institute spearhead hundreds of potentially life-changing, groundbreaking initiatives to help find new treatments for heart disease. We’ve advanced care for a multitude of heart diseases, including:
Lutonix is a registered trademark of BD BARD and used with permission.
WATCHMAN is a trademark of Boston Scientific and used with permission.
TandemHeart is a registered trademark of LivaNova, Inc. and used with permission.
Impella is a registered trademark of ABIOMED and used with permission.